Sun Pharma Q4 FY25 Results: PAT falls 19%, disappoints analysts; 550% dividend declared
Sun Pharma Q4 FY25 Earnings: Sun Pharma, a Mumbai-headquartered pharmaceutical giant, on Thursday reported a consolidated net profit of Rs 2,154 crore for the quarter ended March 31, missing analysts’ estimates. The quarterly net profit fell 19 per cent compared with the corresponding period a year ago, according to a regulatory filing. The drug maker’s March-quarter…
